Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Myelodysplastic Syndromes 62Hodgkin Disease 57Leukemia 56Leukemia, Lymphocytic, Chronic, B-Cell 55Multiple Myeloma 51Lymphoma, Non-Hodgkin 48Lymphoma 44Myeloproliferative Disorders 37Graft vs Host Disease 37Lymphoma, Follicular 36Congenital Abnormalities 36Lymphoma, Large B-Cell, Diffuse 35Leukemia, Myeloid, Accelerated Phase 35Lymphoma, Mantle-Cell 34Lymphoma, B-Cell, Marginal Zone 31Leukemia, Myeloid, Chronic-Phase 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Hematologic Neoplasms 29Burkitt Lymphoma 28Leukemia, Myelomonocytic, Chronic 27Blast Crisis 27Primary Myelofibrosis 26Neoplasms, Plasma Cell 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Waldenstrom Macroglobulinemia 17Lymphoma, T-Cell, Cutaneous 16Anemia, Refractory, with Excess of Blasts 16

Interventions

Tacrolimus 1Salpingo-oophorectomy 1Magnetic Resonance Imaging 1Immunologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Paraneoplastic Syndromes × Tacrolimus × Clear all
NCT00378326 2023-09-18

Immunotherapy of the Paraneoplastic Syndromes

Rockefeller University

Phase NA Completed
26 enrolled 6 charts

Paraneoplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡